Genotyping of hepatitis E virus in clinical specimens by restriction endonuclease analysis.
The genomic variability of hepatitis E virus (HEV) was examined by restriction endonuclease analysis (REA) of four genomic cDNA copies comprising a 499 bp segment of the putative polymerase gene, a 264 bp segment of the helicase gene, and two, 680 bp and 448 bp, segments of the capsid gene. Analysis of the deduced restriction sites of all 27 HEV sequences currently available in the GenBank, and digestion of reverse-transcribed and nested PCR amplified segments obtained from six Nepali isolates were used to devise and test a REA genotyping assay. The assay allowed easy discrimination between the Mexico and Asian genotypes, and the classification of the Asian genotypes into three, or perhaps four subgenotypes. In addition, endonucleases identifiers of individual isolate or clusters of isolates were found. This assay permits rapid identification of a large number of HEV isolates directly from clinical specimens for studies on the molecular epidemiology and evolution of HEV.
Gouvea
V
V
Department of Virus Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA. dr._vera_gouvea@wrsmtp-ccmail.army.mil
Hoke
C H
CH
Innis
B L
BL
D004262:DNA Restriction Enzymes / Q000378:metabolism*; D004279:DNA, Viral / Q000235:genetics / Q000378:metabolism; D014644:Genetic Variation; D005838:Genotype; D016751:Hepatitis E / Q000453:epidemiology / Q000821:virology; D016752:Hepatitis E virus / Q000145:classification* / Q000235:genetics; D006801:Humans; D016133:Polymerase Chain Reaction; D000091402:Prohibitins; D015183:Restriction Mapping; D013045:Species Specificity; D014158:Transcription, Genetic
D004279:DNA, Viral; C000717331:PHB2 protein, human; D000091402:Prohibitins; D004262:DNA Restriction Enzymes